Schedule 13D ownership disclosure

Tokai Pharmaceuticals Inc

Security class unavailable · CUSIP: 67011N204

Event date: 2020-12-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-20-000932
Form type
SC 13D/A
Filer
Eledon Pharmaceuticals, Inc.
CIK
CIK 1404281
Filed
Dec 04, 2020
Reporting period
Dec 02, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub